Skip to content
Home/Companies/Biotech/Entelo Bio
Entelo Bio

Entelo Bio

Biotech·Germany·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Entelo Bio?

Entelo Bio is currently owned by Ananda Impact Ventures through Ananda Impact Fund IV (2022 vintage), since 2024.

Hand-verified · updated 2026-07-03

Ananda Impact Ventures
Investor
Ananda Impact Ventures
Ananda Impact Fund IV · 2022 · Impact

Key facts

HQGermany
SectorBiotech
StatusActive
Websitewww.entelo.bio

More from Ananda Impact Fund IV

Other portfolio companies in the same fund.

Jua
Active
AI/MLSwitzerland· 2025
Mycolever
Active
IndustrialsGermany· 2025
Nordic Salt Cycle
Active
IndustrialsDenmark· 2025
Pheiron
Pheiron
Active
BiotechGermany· 2025
Pulsetrain
Active
ClimateTechGermany· 2025
Decade
Active
ClimateTechGermany· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Entelo Bio

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Entelo Bio?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Entelo Bio.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue